Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
for
Transverse Myelitis
Location: Dallas TX
Sponsor: Q Therapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT03887273
Phase1, Phase2, Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, Tyler TX, Houston TX, San Antonio TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Dallas TX, Austin TX, Tulsa OK, Kansas City MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Irving TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Richardson TX, Austin TX, Oklahoma City OK,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Richardson TX, Austin TX, Oklahoma City OK, Bellaire TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase2, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Dallas TX, Wichita Falls TX, Oklahoma City OK,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: Irving TX, Dallas TX, Mesquite TX, Fort Worth TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
for
Multiple Sclerosis (MS) Primary Progressive
Location: Sherman TX, San Antonio TX, Cordova TN, Roeland Park KS,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07067463
Phase3, Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis
Location: Sherman TX, Oklahoma City OK, San Antonio TX,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07299019
Phase3, Recruiting
Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
for
Transthyretin (TTR) Amyloid Cardiomyopathy
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 30 - 70+
Code: NCT07196839
Recruiting
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
for
Parkinson's Disease
Location: Sherman TX, Houston TX, San Antonio TX, Aurora CO,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT02071134
Recruiting
Temporomandibular Joint (TMJ) Positioning Accuracy and Efficiency Using a Dental Compass.
for
Temporomandibular Joint Syndrome
Location: Gainesville TX
Sponsor: Dr. Dean Reeves Clinic
Sex: All
Age: 18 - 70+
Code: NCT06619574
Recruiting
Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis
for
Severe Sepsis
Location: Acton TX
Sponsor: Bluejay Diagnostics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05048927
Recruiting
Life Story Questionnaire and Physical Therapy Participation
for
Dementia Alzheimers
Location: Weatherford TX
Sponsor: Texas Tech University Health Sciences Center
Sex: All
Age: 60 - 70+
Code: NCT05827276
Recruiting
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age